Capstone Therapeutics Corp (CAPS) - OTCQB
  • Nov. 6, 2014, 11:21 AM
    • Capstone Therapeutics (OTCQB:CAPS) will report Q3 results on November 13 after the close. The conference call will begin at 4:30 pm ET.
    | Nov. 6, 2014, 11:21 AM
  • Aug. 14, 2014, 11:10 AM
    • Capstone Therapeutics (OTCQB:CAPS) Q2 results: Revenues: $0; Operating Expenses: $1.4M (+35.9%); Net Loss: ($1.4M) (-38.0%); Loss Per Share: ($0.03) (-50.0%); Quick Assets: $4.2M (-33.0%).
    • No financial guidance given.
    | Aug. 14, 2014, 11:10 AM
Company Description
Capstone Therapeutics Corp. is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions.
Sector: Healthcare
Industry: Biotechnology
Country: United States